Goldman Sachs’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-323,313
Closed -$20.8M 6033
2018
Q3
$20.8M Sell
323,313
-87,671
-21% -$5.34M 0.01% 1878
2018
Q2
$20.1M Sell
410,984
-115,417
-22% -$5.97M 0.01% 1873
2018
Q1
$24.7M Buy
526,401
+361,417
+219% +$17.4M 0.01% 1678
2017
Q4
$8.22M Sell
164,984
-56,386
-25% -$2.8M ﹤0.01% 2612
2017
Q3
$12.8M Buy
221,370
+45,171
+26% +$2.69M ﹤0.01% 2346
2017
Q2
$11.8M Sell
176,199
-232,085
-57% -$14.7M ﹤0.01% 2372
2017
Q1
$26.7M Buy
408,284
+206,584
+102% +$12.8M 0.01% 1697
2016
Q4
$11.5M Buy
201,700
+44,761
+29% +$2.59M ﹤0.01% 2355
2016
Q3
$9.29M Sell
156,939
-91,770
-37% -$5.51M ﹤0.01% 2512
2016
Q2
$16.3M Buy
248,709
+7,275
+3% +$495K 0.01% 1950
2016
Q1
$16.7M Buy
241,434
+109,926
+84% +$7.34M 0.01% 1849
2015
Q4
$9.65M Buy
131,508
+30,238
+30% +$2.15M ﹤0.01% 2275
2015
Q3
$7.18M Sell
101,270
-49,877
-33% -$4.05M ﹤0.01% 2549
2015
Q2
$13.1M Buy
151,147
+84,167
+126% +$6.36M ﹤0.01% 2126
2015
Q1
$4.92M Buy
66,980
+15,135
+29% +$1.07M ﹤0.01% 2923
2014
Q4
$3.73M Sell
51,845
-53,860
-51% -$3.73M ﹤0.01% 3258
2014
Q3
$7.31M Buy
105,705
+20,070
+23% +$1.41M ﹤0.01% 2647
2014
Q2
$5.32M Buy
85,635
+17,581
+26% +$1.03M ﹤0.01% 2970
2014
Q1
$3.71M Sell
68,054
-1,874
-3% -$100K ﹤0.01% 3369
2013
Q4
$3.69M Buy
69,928
+1,227
+2% +$61.6K ﹤0.01% 3425
2013
Q3
$3.2M Buy
68,701
+3,419
+5% +$164K ﹤0.01% 3430
2013
Q2
$3.19M Buy
+65,282
New +$3.13M ﹤0.01% 3214

Other funds holding LPNT

Goldman Sachs's LPNT Position: Q4 2018 in Review

Goldman Sachs sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 323,313 shares — an estimated $20.8M sold.

Goldman Sachs first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $26.7M in Q1 2017. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Goldman Sachs reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Goldman Sachs sold 323,313 LifePoint Health, Inc. shares in Q4 2018, an estimated $20.8M.
  • Goldman Sachs first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
  • Goldman Sachs's LifePoint Health, Inc. position peaked at $26.7M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.